PHILLIP WILLIAM KEMPF (M. D.) – Rheumatology Physician, NPI 1386662286
Preparing for Medicare enrollment?
Use our CMS-855 prep checklist: which form applies (855I, 855O, or 855A), readiness score, NPPES field map, and Section 12 documents. Reassignment uses CMS-855I Section 4F—not the discontinued CMS-855R form.
Open Medicare 855 Prep tool →Rheumatology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
Provider Addresses for PHILLIP WILLIAM KEMPF (M. D.)
1635 N GEORGE MASON DR STE 220
ARLINGTON, VA 222053606
Phone: (703) 525-3069
Fax: (703) 525-3850
Mailing address matches the actual address.
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 191 Open Payments records for all available years, with a total value of $38,081.
Total Amount is formed as General ($38,081) + Research ($0) + Ownership ($0) = $38,081.
Last reported payment date: 2024-08-13 • Largest payer in this snapshot: Mallinckrodt Hospital Products Inc. ($23,170).
Total Amount
$38,081
General + Research + Ownership
Payments
191
Total payment records
General Amount
$38,081
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-08-13
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Mallinckrodt Hospital Products Inc. | $23,170 |
| AstraZeneca Pharmaceuticals LP | $8,557 |
| Amgen Inc. | $3,963 |
| Janssen Biotech, Inc. | $424 |
| Horizon Therapeutics plc | $335 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
No Medicare enrollment or revalidation data available for this provider in our database.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 180,600 | 65 | $0 |
| J0897 | Injection, denosumab, 1 mg | 13,380 | 177 | $0 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,600 | 14 | $0 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 6,600 | 12 | $0 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,230 | 14 | $0 |
Insurance plans in this area (ZIP 22205)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| RHEUMATOLOGY | VA | 96415 | Infusion of chemotherapy into a vein | 230 | 35 |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.